Clinical Significance of Tumor Infiltrating Lymphocytes and Modulation by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases
Abstract
Simple Summary Colorectal cancer frequently spreads to the liver, where tumors resist immunotherapy through poorly understood mechanisms. Using quantitative multiplexed immunofluorescence in two independent patient cohorts, we measured CD4+, CD8+, and FOXP3+ regulatory T-cells in matched primary tumors and liver metastases. We found that high CD8+ T-cell infiltration in the tumor compartment of liver metastases was independently associated with significantly better overall survival. Neoadjuvant chemotherapy increased T-cell infiltration but did not improve survival outcomes, suggesting chemotherapy alone cannot restore effective anti-tumor immunity in this setting. These findings identify CD8+ T-cells as a clinically meaningful biomarker in colorectal liver metastases and highlight the need for targeted strategies to enhance immune function at metastatic sites.